Technical References ( Melanoma )
728. THE ROLE OF MELANOMA TUMOR-DERIVED NITRIC OXIDE IN THE TUMOR INFLAMMATORY MICROENVIRONMENT: ITS IMPACT ON THE CHEMOKINE EXPRESSION PROFILE, INCLUDING SUPPRESSION OF CXCL10.
Tanese1,2, K., Grimm1, E.A. and Ekmekcioglu1, S. 1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX. 2Department of Dermatology, School of Medicine, Keio University, Tokyo, Japan. Int. J. Cancer, 131, 891–901 (2012).
668. RECONSTRUCTED HUMAN SKIN MODEL TO STUDY MELANOMA AT DIFFERENT STAGES OF PROGRESSION.
Kaluzhny, Y., Ayehunie, S., and Klausner, M. MatTek Corporation, Ashland, MA, USA. Presented at Soc. Invest. Derma., Meeting, May 2011. J. of Invest. Derma., (131, Suppl. 1, Abstract 771 (2011).
623. TAT-MEDIATED DELIVERY OF A DNA REPAIR ENZYME TO SKIN CELLS RAPIDLY INITIATES REPAIR OF UV-INDUCED DNA DAMAGE.
Johnson1, J.L., Lowell1, B.C., Ryabinina1, O.P., Lloyd1,2,3, R.S. and McCullough1,2,3, A.K. 1Center for Research on Occupational and Environmental Toxicology, Oregon Health and Science University, Portland, Oregon, USA. 2The Department of Molecular and Medical Genetics, Oregon Health and Science University, Portland, Oregon, USA and 3Restoration Genetics, Portland, Oregon, USA. J. of Invest. Dermatology, advance online publication, 7 October 2010.
618. PROTEOMIC ANALYSIS OF LASER MICRODISSECTED MELANOMA CELLS FROM SKIN ORGAN CULTURES.
Hood1,2, B.L., Grahovac3, J., Flint1,2, M.S., Sun1,2,M., Charro2, N., Becker3, D., Wells, A., and Conrads1,3, T.P. 1Departments of Pharmacology & Chemical Biology, University of Pittsburgh. 2Mass Spectrometry Platform, University of Pittsburgh. 3Department of Pathology, University of Pittsburgh. 4Pittsburgh VA HealthCare System. J. of Proteome Research, 9, 3656-3663, 2010.
601. INHIBITORY EFFECTS OF Á-ARBUTIN ON MELANIN SYNTHESIS IN CULTURED HUMAN MELANOMA CELLS AND A THREE-DIMENSIONAL HUMAN SKIN MODEL.
Sugimoto1, K., Nishimura1, T., Nomura1,K., Sugimoto2, K., and Kurikia1, T. 1Biochemical Research Laboratory, Ezaki Glico Co., Ltd.; Osaka, Japan and 2Laboratory of Applied Molecular Biology, Division of Applied Biochemistry, Graduate School of Agriculture and Biological Sciences, Osaka Prefecture University, Osaka, Japan. Biol. Pharm. Bull., 27, 4, 510-514, 2004.
525. UPREGULATION OF SOX9 INHIBITS THE GROWTH OF HUMAN AND MOUSE MELANOMAS AND RESTORES THEIR SENSITIVITY TO RETINOIC ACID.
Passeron, T., Valencia, J.C., Namiki, T., Vieira, W.D., Passeron, H., Miyamura, Y., and Hearing, V.J. Laboratory of Cell Biology, National Cancer Institute, NIH, Bethesda, Maryland, USA. J. Clin. Invest., 119, 954-963 (2009).
504. 1-(2,4-DIHYDROXYPHENYL)-3-(2,4-DIMETHOXY-3-METHYL-PHENYL)PROPANE, A NOVEL TYROSINASE INHIBITOR WITH STRONG DEPIGMENTING EFFECTS.
Nesterov1, A., Zhao1, J., Minter2, D., Hertel1, C., Ma1, W., Abeysinghe1, P., Hong1, M., and Jia1, Q. 1Unigen Pharmaceuticals, Inc.; 2660 Willamette Drive NE, Lacey, WA 98516, U.S.A.: and 2Chemistry Department, Texas Christian University; Fort Worth, TX 76129, USA. Chem. Pharm. Bull., 56(9) 1292-1296 (2008).
498. A SMALL-MOLECULE E2F INHIBITOR BLOCKS GROWTH IN A MELANOMA CULTURE MODEL.
Ma1, Y., Kurtyka1, C.A., Boyapalle1, S., Sung2, S-S. Lawrence2, H., Guida2, W., and Cress1, W.D. 1Molecular Oncology Program and 2High Throughput Screening and Chemistry Core Facility, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. Cancer Res., 68 (15):6292–9 (2008).
455. ROSCOVITINE INHIBITS DIFFERENTIATION AND INVASION IN A THREE-DIMENSIONAL SKIN RECONSTRUCTION MODEL OF METASTATIC MELANOMA.
Mohapatra1, S., Coppola1, D., Riker2, A.I., and Pledger1, W.J. 1Department of Interdisciplinary Oncology, H. Lee Moffitt Cancer Center and Research Institute and the University of South Florida Medical Center, Tampa, Florida, 2University of South Alabama-Mitchell Cancer Institute, Mobile, Alabama. Mol Cancer Res; 5, (2), 145–51, (2007).
365. RECONSTRUCTED HUMAN SKIN MODEL TO STUDY MELANOMA AT DIFFERENT STAGES OF PROGRESSION.
Kaluzhny, Y., Sur, G., Klausner, M. MatTek Corporation, Ashland, MA, United States. Presented at Society of Investigative Dermatology, St.Louis, MO, May 4-7, (2005).
326. HUMAN MELANOMA DEVELOPMENT IN RECONSTRUCTED SKIN MODELS.
Kubilus, J., Neal, P., Kaluzhny, Y., Sur, G., and Klausner, M. MatTek Corporation, Ashland, MA. J. Invest. Dermatol., 122, (3), A158, Abstract #945, (2004).
www.MatTek.co.kr
